Shares outstanding decreased 1.5%
Shares outstanding changed -1.5% from the comparable as-filed period. The change ranks at the 100th percentile of 7 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding changed -1.5% from the comparable as-filed period. The change ranks at the 100th percentile of 7 prior comparable changes.
Current liabilities changed +50.8% from the comparable as-filed period.
Free-cash-flow proxy changed -17.6% from the comparable as-filed period.
Noncurrent long-term debt changed -20.6% from the comparable as-filed period.
Operating cash flow changed -16.5% from the comparable as-filed period.
Current ratio changed -28.4% from the comparable as-filed period.
Debt / assets changed -461 basis points from the comparable as-filed period.
Working capital / assets changed -607 basis points from the comparable as-filed period.
Operating margin changed -64 basis points from the comparable as-filed period.
Operating cash-flow margin changed -448 basis points from the comparable as-filed period.
Debt / revenue changed -2434 basis points from the comparable as-filed period.
Free-cash-flow margin changed -454 basis points from the comparable as-filed period.
Revenue changed +7.8% from the comparable as-filed period.
Net income changed +13.7% from the comparable as-filed period.
Working capital changed -127.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Operating cash flow / net income changed -26.5% from the comparable as-filed period.
Gross margin changed +31 basis points from the comparable as-filed period.
Gross debt changed -6.0% from the comparable as-filed period.
Reported total debt changed -6.0% from the comparable as-filed period.
Current assets changed +7.9% from the comparable as-filed period.
Operating income changed +4.2% from the comparable as-filed period.
Net debt changed -6.2% from the comparable as-filed period.
Selling, general & administrative changed +15.8% from the comparable as-filed period.
Total assets changed +5.8% from the comparable as-filed period.
Stock-based compensation changed +17.4% from the comparable as-filed period.
Capital expenditure changed +18.3% from the comparable as-filed period.
Cash & equivalents changed -3.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capex / revenue changed +6 basis points from the comparable as-filed period.
Cost of revenue changed +7.3% from the comparable as-filed period.
SBC / revenue changed +10 basis points from the comparable as-filed period.
Cash / debt changed +21 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.